Entrepreneur-in-Residence
Rick Dewey, M.D.
Background
Rick joined Versant Ventures in 2024 as an Entrepreneur-in-Residence based in Boston and New York City. He brings over 15 years of experience discovering and translating insights from the human genome into new medicines and healthcare paradigms.
Prior to joining Versant, Rick served as Chief Scientific Officer of Foresite Labs, directing efforts and teams using data science, computational biology, and principles of precision medicine to create, incubate, and launch therapeutics and healthcare companies.
Previously, he served as Head of Translational Genetics at Regeneron Genetics Center. In this role, he built and led teams that used large-scale human genomics to systematically understand human biology and disease pathogenesis, critically evaluate therapeutic targets in all stages of discovery and development, and discover novel therapeutic targets, several of which are now being pursued in late-stage clinical trials.
History
Rick is a board-certified physician-scientist trained in Internal Medicine, Cardiology and Human Genetics at Stanford Hospital and Clinics. He holds an A.B. in Chemistry and Physics from Harvard University and an M.D. with concentration in cardiovascular and pulmonary sciences from Stanford University School of Medicine. His research work has been published in peer-reviewed journals such as the New England Journal of Medicine, Science and Nature.